Four health tech companies closed a combined $335 million in funding during June 2026, according to MarketScale. Every round targeted AI agent platforms for patient operations: scheduling, chronic disease monitoring, home health logistics, and workforce training. The concentration of capital in a single month signals that health systems have moved past pilot programs into production deployment.
The Rounds
Assort Health led with a $120 million Series C at a $1.2 billion valuation, according to the company’s announcement. Menlo Ventures led the round, with Lightspeed Venture Partners, Felicis, First Round Capital, and others participating. Assort has now raised $222 million total. The platform handles scheduling, intake, referrals, document processing, medication refills, and payments, built on more than 190 million patient interactions.
Cadence raised $100 million in its Series C led by Spark Capital for clinical AI focused on chronic disease management. The investor list tells the real story: Corewell Health Ventures, Memorial Hermann, and Duke Health all participated alongside financial investors including Thrive Capital, General Catalyst, and Coatue. Health systems writing checks into their own vendor’s funding round is not speculative positioning. It is procurement conviction backed by operating data. Cadence currently works with more than 20 health systems and monitors over 100,000 patients, according to MarketScale.
Adaptive Innovations closed $60 million across a $50 million Series A and $10 million seed round for its AI operating system for home health. Felicis and Bain Capital Ventures led, with Optum Ventures among participants. The company launched in 2025 and has already conducted over 100,000 patient visits, partnering with more than 500 referring healthcare organizations.
Stepful rounded out the group with $55 million in Series C funding led by Oak HC/FT. The platform trains healthcare workers online and connects graduates to provider job opportunities. Intermountain Health and ECMC Education Impact Fund participated.
Health Systems as Investors
The most revealing signal in this round of funding is not the dollar amounts. It is who wrote the checks. Three major health systems, Corewell Health, Memorial Hermann, and Duke Health, co-invested in Cadence alongside traditional venture capital. Optum Ventures backed Adaptive Innovations. Intermountain Health backed Stepful. When the buyers start funding the vendors, the evaluation phase is over.
This pattern mirrors what happened in electronic health records a decade ago. Health systems invested in EHR companies they were already using, effectively locking in their deployment roadmaps. The difference now is speed: Assort Health claims 190 million patient interactions on its platform, and Cadence monitors 100,000 patients across 20 health systems. These are production numbers, not proofs of concept.
The Interoperability Ceiling
Every one of these platforms depends on clean, connected data to function. Scheduling agents need to read existing appointment systems. Chronic care monitors need EHR access. Home health coordinators need referral documentation. A Concord Technologies report published in July through an American Hospital Association Market Scan examined this exact constraint, finding that AI-driven interoperability remains the common prerequisite for agent deployment in healthcare.
The $335 million is real capital flowing into a vertical where AI agents have measurable operational impact. Health tech is now the clearest proof point that agent platforms can monetize outside of software development.